Gianni Infantino said player health and welfare remains a key consideration for the global governing body amid concerns about ...

A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The General Services Administration has a key role in the Trump administration’s quest to slash costs and bring the federal government to heel ...

With privacy updates, smarter audiences and stricter inbox rules, here’s how to modernize your email strategy. The post Three ...

BRIDGEWATER, NJ, USA and BENGALURU, Karnataka, India I April 15, 2025 I Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and ...

Biotech giant Bristol-Myers Squibb Company BMY is scheduled to report first-quarter 2025 results on April 24, before market ...

We do our best to keep you up-to-date on all of the latest Netflix releases, but with dozens of new shows and movies hitting ...

The global generic drugs market size has been calculated at $468.08 billion in 2025 and is estimated to be worth $728.64 ...

gaining exclusivity over other generic versions of the same drug for several months. This is advantageous to generic players, especially in the case of complex generics, which require significant ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers ...